Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India flag India · Delayed Price · Currency is INR
22.94
-1.06 (-4.42%)
At close: Jun 1, 2026

BOM:531015 Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
266298149---
Market Cap Growth
86.06%99.78%----
Enterprise Value
257317153---
Last Close Price
22.9425.7728.52---
PE Ratio
109.24120.26----
PS Ratio
3.313.7218.51---
PB Ratio
1.882.123.39---
P/TBV Ratio
1.882.123.39---
EV/Sales Ratio
3.203.9618.94---
EV/EBITDA Ratio
213.28263.64----
EV/EBIT Ratio
220.61272.70----
Debt / Equity Ratio
0.020.020.01-0.54-0.49-0.37
Debt / EBITDA Ratio
2.752.75----
Debt / FCF Ratio
---160.04-0.18
Net Debt / Equity Ratio
-0.06-0.06-0.55-0.54-0.49-0.37
Net Debt / EBITDA Ratio
-7.41-7.412.34-3.34-1.89-2.74
Net Debt / FCF Ratio
0.080.081.06158.91-113.480.18
Asset Turnover
0.750.750.31---
Inventory Turnover
13.7913.79----
Quick Ratio
3.843.844.580.020.040.03
Current Ratio
7.957.956.780.020.150.12
Return on Equity (ROE)
2.68%2.68%-0.56%---
Return on Assets (ROA)
0.68%0.68%-24.94%-47.69%-56.94%-32.72%
Return on Invested Capital (ROIC)
0.85%1.37%-124.82%---
Return on Capital Employed (ROCE)
0.80%0.80%-23.70%17.30%27.30%14.60%
Earnings Yield
0.93%0.83%-0.07%---
FCF Yield
--36.84%-15.33%---
Buyback Yield / Dilution
-125.60%-125.60%----0.00%